Predicting response to immune checkpoint blockade in NSCLC with tumour-only RNA-seq
Details
Publication Year 2023-04,Volume 128,Issue #6,Page 1148-1154
Journal Title
British Journal of Cancer
Publication Type
Research article
Abstract
BACKGROUND: Targeted RNA sequencing (RNA-seq) from FFPE specimens is used clinically in cancer for its ability to estimate gene expression and to detect fusions. Using a cohort of NSCLC patients, we sought to determine whether targeted RNA-seq could be used to measure tumour mutational burden (TMB) and the expression of immune-cell-restricted genes from FFPE specimens and whether these could predict response to immune checkpoint blockade. METHODS: Using The Cancer Genome Atlas LUAD dataset, we developed a method for determining TMB from tumour-only RNA-seq and showed a correlation with DNA sequencing derived TMB calculated from tumour/normal sample pairs (Spearman correlation = 0.79, 95% CI [0.73, 0.83]. We applied this method to targeted sequencing data from our patient cohort and validated these results against TMB estimates obtained using an orthogonal assay (Spearman correlation = 0.49, 95% CI [0.24, 0.68]). RESULTS: We observed that the RNA measure of TMB was significantly higher in responders to immune blockade treatment (P = 0.028) and that it was predictive of response (AUC = 0.640 with 95% CI [0.493, 0.786]). By contrast, the expression of immune-cell-restricted genes was uncorrelated with patient outcome. CONCLUSION: TMB calculated from targeted RNA sequencing has a similar diagnostic ability to TMB generated from targeted DNA sequencing.
Publisher
Springer Nature
Keywords
Humans; *Lung Neoplasms/drug therapy; Immune Checkpoint Inhibitors/therapeutic use; RNA-Seq; Mutation; *Antineoplastic Agents, Immunological/therapeutic use; *Carcinoma, Non-Small-Cell Lung/drug therapy; Sequence Analysis, RNA; Rna; Biomarkers, Tumor/genetics
Department(s)
Pathology; Laboratory Research
PubMed ID
36572732
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2023-08-03 07:58:18
Last Modified: 2023-08-03 08:01:33

© 2024 The Walter and Eliza Hall Institute of Medical Research. Access to this website is subject to our Privacy Policy and Terms of Use

An error has occurred. This application may no longer respond until reloaded. Reload 🗙